129 related articles for article (PubMed ID: 33119142)
1. Decision support for men with prostate cancer: Concordance between treatment choice and tumor risk.
Filson CP; Hong F; Xiong N; Pozzar R; Halpenny B; Berry DL
Cancer; 2021 Jan; 127(2):203-208. PubMed ID: 33119142
[TBL] [Abstract][Full Text] [Related]
2. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
[TBL] [Abstract][Full Text] [Related]
3. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.
Trinh QD; Hong F; Halpenny B; Epstein M; Berry DL
Urol Oncol; 2020 Mar; 38(3):78.e7-78.e13. PubMed ID: 31883873
[TBL] [Abstract][Full Text] [Related]
5. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
[TBL] [Abstract][Full Text] [Related]
6. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
[TBL] [Abstract][Full Text] [Related]
7. When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer.
Underhill ML; Hong F; Berry DL
Health Qual Life Outcomes; 2014 Oct; 12():159. PubMed ID: 25344101
[TBL] [Abstract][Full Text] [Related]
8. Does Patient Preference Measurement in Decision Aids Improve Decisional Conflict? A Randomized Trial in Men with Prostate Cancer.
Shirk JD; Crespi CM; Saucedo JD; Lambrechts S; Dahan E; Kaplan R; Saigal C
Patient; 2017 Dec; 10(6):785-798. PubMed ID: 28623628
[TBL] [Abstract][Full Text] [Related]
9. Decision Support with the Personal Patient Profile-Prostate: A Multicenter Randomized Trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M; Somayaji P
J Urol; 2018 Jan; 199(1):89-97. PubMed ID: 28754540
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of the personal patient profile-prostate (P3P), a Web-based decision support system for men newly diagnosed with localized prostate cancer.
Berry DL; Halpenny B; Wolpin S; Davison BJ; Ellis WJ; Lober WB; McReynolds J; Wulff J
J Med Internet Res; 2010 Dec; 12(4):e67. PubMed ID: 21169159
[TBL] [Abstract][Full Text] [Related]
11. Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer.
Berry DL; Wang Q; Halpenny B; Hong F
Patient Educ Couns; 2012 Aug; 88(2):262-7. PubMed ID: 22608696
[TBL] [Abstract][Full Text] [Related]
12. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
13. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
[TBL] [Abstract][Full Text] [Related]
14. Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT.
Diefenbach MA; Benedict C; Miller SM; Stanton AL; Ropka ME; Wen KY; Fleisher LG; Mohamed NE; Hall SJ
Transl Behav Med; 2018 Nov; 8(6):876-886. PubMed ID: 29982747
[TBL] [Abstract][Full Text] [Related]
15. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
16. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.
Broughman JR; Basak R; Nielsen ME; Reeve BB; Usinger DS; Spearman KC; Godley PA; Chen RC
J Natl Cancer Inst; 2018 Apr; 110(4):420-425. PubMed ID: 29045679
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
Thurtle D; Jenkins V; Freeman A; Pearson M; Recchia G; Tamer P; Leonard K; Pharoah P; Aning J; Madaan S; Goh C; Hilman S; McCracken S; Ilie PC; Lazarowicz H; Gnanapragasam V
Eur Urol; 2021 Nov; 80(5):661-669. PubMed ID: 34493413
[TBL] [Abstract][Full Text] [Related]
19. Differences in treatment choices between prostate cancer patients using a decision aid and patients receiving care as usual: results from a randomized controlled trial.
Lamers RED; Cuypers M; de Vries M; van de Poll-Franse LV; Bosch JLHR; Kil PJM
World J Urol; 2021 Dec; 39(12):4327-4333. PubMed ID: 34272972
[TBL] [Abstract][Full Text] [Related]
20. Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.
Jayadevappa R; Chhatre S; Gallo JJ; Wittink M; Morales KH; Lee DI; Guzzo TJ; Vapiwala N; Wong YN; Newman DK; Van Arsdalen K; Malkowicz SB; Schwartz JS; Wein AJ
J Clin Oncol; 2019 Apr; 37(12):964-973. PubMed ID: 30860943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
